Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients. (Q46480579)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Lars Henning Engelholm

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

William G Stetler-Stevenson

11 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Hans Jørgen Nielsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Larsen MB

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Brünner N

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Christensen IJ

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Høyer-Hansen G

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

449-460

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15882437%20AND%20SRC:MED&resulttype=core&format=json

The plasminogen activation system in tumor growth, invasion, and metastasis

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Changing views of the role of matrix metalloproteinases in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Tissue inhibitors of metalloproteinases: evolution, structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

High levels of TIMP-2 correlate with adverse prognosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Chicken IgY: utilizing the evolutionary difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01585.X